Vivani Medical
VANI
33 hedge funds and large institutions have $4.45M invested in Vivani Medical in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.
13% more capital invested
Capital invested by funds: $3.93M → $4.45M (+$522K)
0% more funds holding
Funds holding: 33 → 33 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
1.21% less ownership
Funds ownership: 8.45% → 7.24% (-1.2%)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$56K |
| 2 |
Charles Schwab
San Francisco,
California
|
+$37K |
| 3 |
Jane Street
New York
|
+$24.1K |
| 4 |
HF
HRT Financial
New York
|
+$17.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.2K |
Top Sellers
VANI Hedge Fund Activity: Q2 2023 in Review
33 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2023, worth a combined $4.45M — up 13% from $3.93M a quarter earlier.
Fund positioning in VANI was balanced in Q2 2023: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 9 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $56K. The largest seller was Tanager Wealth Management, cutting an estimated $594K.
- 33 institutional investors held Vivani Medical (VANI) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $4.45M of Vivani Medical stock for Q2 2023, up 13% quarter-over-quarter.
- 5 funds opened new Vivani Medical positions in Q2 2023 and 5 closed out, a net change of 0 holders.
- The largest Vivani Medical buyer in Q2 2023 was Geode Capital Management, an estimated $56K added.
- The largest Vivani Medical seller in Q2 2023 was Tanager Wealth Management, an estimated $594K sold.
Based on aggregated 13F filings for Q2 2023.